Medicine and Dentistry
Diseases
100%
Randomized Controlled Trial
91%
Diabetes
89%
Systematic Review
75%
Cardiovascular Disease
72%
Maturity Onset Diabetes of the Young
66%
Apoplexy
64%
Meta-Analysis
61%
Familial Hypercholesterolemia
57%
Blood Pressure
57%
Cardiovascular System
56%
Prevalence
52%
Clinical Trial
52%
Placebo
51%
Malignant Neoplasm
51%
Quality of Life
50%
Health Care Cost
47%
Infection
46%
Hazard Ratio
43%
Neoplasm
43%
Cohort Analysis
41%
COVID-19
40%
Biological Marker
39%
Odds Ratio
38%
Lipoprotein
35%
Diagnosis
34%
Adverse Event
31%
Cardiovascular Risk
30%
Clinician
29%
Mesothelioma
29%
Atrial Fibrillation
28%
Melanoma
28%
Intensive Care Unit
27%
Pleura Mesothelioma
27%
Observational Study
27%
Kidney Denervation
27%
Prospective Cohort Study
26%
Low Density Lipoprotein Cholesterol
26%
Body Mass Index
26%
Comorbidity
26%
Prostate Cancer
25%
Kidney Graft
25%
Randomized Clinical Trial
25%
Adolescence
24%
Nonalcoholic Fatty Liver
24%
Overall Survival
23%
Coronary Artery Disease
23%
Peritoneal Dialysis
23%
Transplantation
22%
Cross Sectional Study
22%
Frailty
21%
Chronic Kidney Disease
21%
Medicine
21%
Atherosclerosis
19%
Bone Density
19%
Arm
19%
Cost-Effectiveness Analysis
19%
Myocardial Infarction
18%
Congestive Heart Failure
18%
Statin
18%
Lung
18%
Lung Cancer
17%
Metabolic Syndrome
17%
Cancer
17%
Physical Activity
17%
Kidney Transplantation
17%
Pleura Effusion
17%
Systolic Blood Pressure
17%
Emergency Department
17%
Public Health
17%
Proportional Hazards Model
16%
Idiopathic Pulmonary Fibrosis
16%
Global Disease Burden
16%
Glomerular Filtration Rate
15%
Positron Emission Tomography
15%
All Cause Mortality
15%
Fibrosis
15%
Breast Cancer
15%
Recurrent Disease
15%
Triacylglycerol
14%
Intensive Care
14%
Acute Coronary Syndrome
14%
Positron Emission Tomography-Computed Tomography
14%
Asthma
14%
Sodium Glucose Cotransporter 2 Inhibitor
14%
Brain Ischemia
14%
Sympathetic Nervous System
14%
Computer Assisted Tomography
14%
Gene Linkage
13%
Nivolumab
13%
Kidney Function
13%
Dyslipidemia
13%
Pediatrics
13%
Awareness
13%
Drug Therapy
13%
Insulin Dependent Diabetes Mellitus
12%
Mortality Rate
12%
Cohort Effect
12%
Metastatic Carcinoma
12%
Logistic Regression Analysis
12%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
80%
Cardiovascular Disease
65%
Placebo
59%
Randomized Controlled Trial
48%
Non Insulin Dependent Diabetes Mellitus
44%
Lipoprotein A
44%
Clinical Trial
43%
Infection
39%
Prevalence
38%
Cerebrovascular Accident
38%
Malignant Neoplasm
37%
Neoplasm
35%
Adverse Event
35%
Pharmacokinetics
34%
Lipoprotein
32%
Biological Marker
30%
Familial Hypercholesterolemia
28%
Statin (Protein)
27%
Cohort Study
27%
Low Density Lipoprotein Cholesterol
27%
Chemotherapy
25%
Inflammation
24%
Triacylglycerol
24%
Coronary Artery Atherosclerosis
23%
Comorbidity
23%
Cardiovascular Risk
22%
All Cause Mortality
21%
Metabolic Syndrome X
21%
Atrial Fibrillation
21%
Randomized Clinical Trial
21%
Melanoma
19%
Mesothelioma
19%
Overall Survival
19%
Pleura Mesothelioma
19%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
18%
Coronary Artery Disease
18%
Antihypertensive Agent
18%
Prospective Cohort Study
17%
Monotherapy
17%
Congestive Heart Failure
17%
Chronic Kidney Failure
16%
Heart Infarction
16%
Combination Therapy
16%
Observational Study
16%
Nonalcoholic Fatty Liver
15%
Tolerability
15%
Dihydroartemisinin
15%
High Density Lipoprotein Cholesterol
14%
Recurrent Disease
14%
Sodium Glucose Cotransporter 2 Inhibitor
14%
Antimalarial Agent
14%
Fibrosing Alveolitis
14%
Solid Malignant Neoplasm
14%
Nivolumab
14%
Bile Acid
13%
Progression Free Survival
13%
Global Disease Burden
13%
Isoprostane Derivative
13%
Ischemic Heart Disease
12%
Lung Cancer
12%
Rheumatic Heart Disease
12%
Malaria Falciparum
12%
Pharmacotherapy
12%
Dyslipidemia
12%
Ipilimumab
11%
Artesunate
11%
Ethanol
11%
Dexamethasone
11%
Rheumatoid Arthritis
11%
Inflammatory Arthritis
11%
Atherosclerosis
11%
Flavonoid
11%
Remission
11%
Acetylsalicylic Acid
11%
Prostate Cancer
11%
Polyethylene Terephthalate
11%
Diabetes Mellitus
10%
Colchicine
10%
Fibrosis
10%
Nanoparticle
10%
Obesity
10%
Antioxidant
9%
Apolipoprotein
9%
Proprotein Convertase 9
9%
Frailty
9%
Insulin Resistance
9%
Benzathine Penicillin
9%
Resistant Hypertension
9%
Iron
9%
Vitamin D
9%
Acute Coronary Syndrome
9%
Nitric Oxide
8%
High Density Lipoprotein
8%
Piperaquine
8%
Hypertension
8%
Lutetium 177
8%
Pharmacodynamics
8%
Immunotherapy
8%
Asthma
8%
Cross-Sectional Study
8%
Nursing and Health Professions
Confidence Interval
37%
Systematic Review
36%
Blood Pressure
29%
Cerebrovascular Accident
28%
Intensive Care Unit
28%
Diseases
27%
Quality of Life
26%
Odds Ratio
26%
Cardiovascular Disease
25%
Prevalence
23%
Meta Analysis
23%
Practice Guideline
22%
Non Insulin Dependent Diabetes Mellitus
21%
Frailty
18%
Malignant Neoplasm
18%
Aged Care
17%
Hazard Ratio
15%
Health Care Personnel
15%
Cohort Analysis
15%
Peritoneal Dialysis
14%
Familial Hypercholesterolemia
13%
Placebo
13%
Infection
13%
Intensive Care
12%
Hospital Discharge
12%
Health Practitioner
11%
Palliative Therapy
11%
Logistic Regression Analysis
10%
Hospital Readmission
10%
Body Mass
10%
Cost Effectiveness Analysis
9%
Kidney Denervation
9%
Chronic Kidney Failure
9%
Comorbidity
8%
Emergency Ward
8%
Congestive Heart Failure
8%
Coronary Artery Disease
8%
Adolescent
8%
Hospital
8%
Motor Neuron Disease
8%
Health Care
8%
Diagnosis
8%
Body Composition
7%
General Practitioner
7%
Prospective Cohort Study
7%
Health Outcomes
7%
General Practice
7%
Low Density Lipoprotein Cholesterol
7%
Clinical Audit
7%
Cognitive Defect
7%
Pilot Study
7%
Heart Infarction
7%
Volunteer
7%
Atrial Fibrillation
7%
Pleura Mesothelioma
7%
Length of Stay
7%
Proportional Hazards Model
7%
Antihypertensive Agent
7%
Peritonitis
7%
Nutrition Policy
6%
Deprescribing
6%
Pandemic
6%
Muscle Strength
6%
All Cause Mortality
6%
Ward
6%
Rheumatoid Arthritis
6%
Inflammatory Arthritis
6%
Adverse Event
6%
Cystic Fibrosis
6%
Lipoprotein A
6%
Catheter
6%
Depressive Disorder
6%
Hemoglobin A1c
6%
Hospital Mortality
6%
Imaging
6%
Cardiovascular Risk
6%
Systolic Blood Pressure
6%
Model of Care
6%
Primary Medical Care
6%
Patient Referral
5%
Foot Ulcer
5%
Clinical Practice
5%
Cross-Sectional Study
5%
Mild Cognitive Impairment
5%
Transplantation
5%
Patient-Reported Outcome
5%
Statin (Protein)
5%
Combination Therapy
5%
Glucose Blood Level
5%
Rate Ratio
5%
Glioma
5%
Kidney Graft
5%
Treatment Outcome
5%
Outpatient
5%
Biological Marker
5%
Grip Strength
5%
Critical Illness
5%
Clinical Outcome
5%
Health Care Cost
5%
Prematurity
5%